Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENBREL vs ENCORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENBREL vs ENCORAFENIB: Safety Overview

Metric ENBREL ENCORAFENIB
Total FAERS Reports 17,910 8,554
Deaths Reported 312 1,397
Death Rate 1.7% 16.3%
Hospitalizations 1,784 2,334
Average Patient Age 53.4 yrs 64.4 yrs
% Female Patients N/A 50.9%
FDA Approval Date N/A Jun 27, 2018
Manufacturer N/A Array BioPharma Inc.
Route N/A ORAL
Marketing Status N/A Discontinued